BioNTech is a Mainz-based corporate strategic investor and biopharmaceutical company focused on biotechnology, life sciences, oncology and pharmaceuticals. It is relevant for later-stage companies developing immunotherapies, vaccines, precision therapeutics and enabling AI technologies tied to drug discovery or biopharmaceutical operations. Its recorded investment geography includes Tunisia and the United Kingdom.